The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 5 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Fetal Hemoglobin  [Clear All Filters]
Journal Article
Radmilovic, M., Zukic B., Petrovic M. Stojiljkov, Bartsakoulia M., Stankovic B., Kotur N., et al. (2013).  Functional analysis of a novel KLF1 gene promoter variation associated with hereditary persistence of fetal hemoglobin.. Ann Hematol. 92(1), 53-8.
Stratopoulos, A., Kolliopoulou A., Karamperis K., John A., Kydonopoulou K., Esftathiou G., et al. (2019).  Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patients.. Pharmacogenomics. 20(11), 791-801.
Borg, J., Papadopoulos P., Georgitsi M., Gutiérrez L., Grech G., Fanis P., et al. (2010).  Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin.. Nat Genet. 42(9), 801-5.
Borg, J., Phylactides M., Bartsakoulia M., Tafrali C., Lederer C., Felice A. E., et al. (2012).  KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients.. Pharmacogenomics. 13(13), 1487-500.
Kolliopoulou, A., Siamoglou S., John A., Sgourou A., Kourakli A., Symeonidis A., et al. (2019).  Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study.. Hemoglobin. 43(1), 27-33.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.